Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Morrison Foerster Named PEI Asia-Pacific Law Firm of the Year – Transactions for Second Year

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

Morrison Foerster has been named Law Firm of the Year in Asia-Pacific – Transactions at the 2025 Private Equity International...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

About Morrison Foerster

people-default-header-desktop.jpg

people-default-header-mobile.jpg

Default Meta Data

Morrison Foerster has been named Law Firm of the Year in Asia-Pacific – Transactions at the 2025 Private Equity International (PEI) Awards, marking the second consecutive year the firm has earned this recognition. For more than two decades, the annual PEI Awards have recognized the top performing firms, funds, and deals in the private equity industry around the globe.With more than 40 private equity lawyers in Asia, we advise on all types of private equity-related transactions, including buyouts, carve-outs, joint ventures, and minority investments, across high-growth sectors including AI, technology, life sciences, consumer retail, real estate, financial services, and sports and entertainment. Between November 1, 2024, and October 31, 2025, we advised on more than 70 matters with an aggregate value exceeding US$223.4 billion.The firm’s representative matters include advising: (i) <a href="https://www.mofo.com/resources/news/251120-mofo-advises-cpe-on-its-strategic-partnership">CPE</a> on the formation of Burger King China, a strategic joint venture with Restaurant Brands International (NYSE: QSR/TSX: QSR); (ii) <a href="https://www.mofo.com/resources/news/251120-mofo-advises-affinity-equity-partners">Affinity Equity Partners</a> on its sale of Burger King Japan; (iii) <a href="https://www.mofo.com/resources/news/250801-mofo-advises-eqt-on-2-7-billion-tender-offer">EQT</a> on its US$2.7 billion tender offer to privatize Fujitec; and (iv) <a href="https://www.mofo.com/resources/news/250207-mofo-advises-bain-capital">Bain Capital</a> on its JPY510 billion (US$3.3 billion) acquisition of Mitsubishi Tanabe Pharma Corporation.View the full list of <a href="https://www.privateequityinternational.com/pei-awards-2025-asia-pacific-winners/" target="_blank">2025 PEI Award honorees</a> and learn more about <a href="https://www.mofo.com/capabilities/private-equity-investments-buyouts">Morrison Foerster’s private equity capabilities</a>.

Morrison Foerster Named PEI Asia-Pacific Law Firm of the Year – Transactions for Second Year

Sign Up

Randy Laxer is the Co-Head of the Asia M&A/PE Practice. His experience includes over 20 years in Japan representing clients on numerous Japan private equity buyouts and investments, cross-border mergers and acquisitions, international joint ventures, and minority investments in various industries, including high technology, life sciences, and media.Randy has been selected as one of “Asia’s Top 15 M&A Lawyers” by Asian Legal Business and also is recommended for his M&A and corporate law expertise by Chambers Global (2025), Chambers Asia-Pacific (2025), IFLR1000 (2024), and The Legal 500 Asia Pacific (2025). Client comments about Randy include the following:“Randy Laxer is the lawyer I personally trust most in cross-border M&A.” (The Legal 500 Asia Pacific)“When conducting cross-border M&A transactions with a high degree of difficulty, consider using [Randy].” (The Legal 500 Asia Pacific)“Randy has always shown commitment [to this client]” and “is on-top not just of the theme but also of details of any deliverables, oral presentation, negotiation or side-chat seamlessly” (The Legal 500 Asia Pacific).Randy received his J.D cum laude from the University of Michigan Law School and attended Konan University in Kobe, Japan and Stanford University’s Inter-University Center for Japanese Studies. He is fluent in Japanese and is also a registered Gaikokuho-Jimu-Bengoshi and a member of the Daini Tokyo Bar Association.

Randy Laxer

Partner

Nozomi Oda is the Co-Head of the Asia M&A/PE Practice. Her work focuses on cross-border public and private M&A, joint ventures, strategic investments, capital markets, and life sciences.She regularly advises clients on a wide range of Japanese regulations including securities, financial and fund, merger review, and healthcare and life sciences. In addition to her work in private practice, Nozomi spent two years with Japan’s Financial Services Agency (FSA) as a deputy director of the corporate disclosure department, where she participated in the drafting of the FSA’s disclosure regulations regarding private placement offerings and director compensation.Nozomi is recommended in the 2023 edition of The Legal 500 Asia Pacific for Japan: Corporate and M&A and has also been recognized in The Best Lawyers in Japan for Capital Markets, Corporate and M&A, Private Equity, Private Funds and Venture Capital Law.Nozomi is a bengoshi admitted to practice in Japan and New York and a member of the Dai-Ichi Tokyo Bar Association.Nozomi’s experience includes representing:<ul><li>Daiichi Sankyo in its $6.9 billion global drug development and commercialization agreement with AstraZeneca.</li><li>C.R. Bard in its acquisition of Medicon, a Japan-based distributor of medical equipment.</li><li>Nissan Motor in its $2.3 billion acquisition of a 34% stake in Mitsubishi Motors.</li><li>Starbucks Coffee in its buyout of the remaining 60.5% share of Starbucks Coffee Japan.</li></ul>

Nozomi Oda

Jeremy White is the Co-Head of the Asia M&A/PE Practice. As a corporate partner of our Tokyo office, Jeremy focuses his practice on cross-border mergers, acquisitions, disposals, spin-outs, and joint ventures. His practice covers alliances between multinationals to greenfield corporate and venture investments.Jeremy is rated as one of “Asia’s Top 15 M&A Lawyers” (by Asia Legal Business 2023).Jeremy is recommended as a leading lawyer in Japan by independent guides to the legal profession, including Chambers & Partners, The Legal 500, and IFLR1000. Clients comment that he is “quite simply the best M&A lawyer I have worked with. His knowledge, dedication to client and project, experience and constructive problem-solving approach is unmatched in the market” (The Legal 500 2023), “exceptional for cross-border transactions…and an absolute pleasure to work with” (Chambers 2020), “the single best lawyer I have worked with in 30 years of M&A experience…courteous, ruthless on behalf of the client in negotiations, very smart, a creative solution finder, and has pragmatic common sense” (Chambers 2019), and “The best cross border transaction lawyer in Tokyo and all of my clients I introduced love him…” (IFLR1000 2018).

Jeremy White

Xiaoxi Lin has over 15 years’ experience advising private equity and investment fund clients on their most complex and strategic transactions, including control and leveraged buyouts, growth capital investments and public takeovers.Xiaoxi is one of the most experienced practitioners in Asia in U.S. public transactions, including take privates, PIPE (private investment in public equity) and SPAC/de-SPAC transactions.He has significant experience advising both financial sponsors and corporations on M&A transactions, with a particular focus on the technology, consumer, healthcare and energy sectors, as well as inbound and outbound investments related to China and the U.S.Xiaoxi has advised a wide range of financial sponsors across the U.S. and Asia, including Advantage Partners, Bain, Baring Private Equity Asia (now EQT Private Capital Asia), Boyu Capital, Carlyle, Centurium Capital, China Everbright, CITIC Capital/Trustar Capital, C Capital, CPE, Canada Pension Plan Investment Board (CPPIB), DCP, Evenstar Capital, Genesis Capital, GF Capital, GP Investments, Hammer Capital, Hillhouse, KKR, Malaysia’s sovereign wealth fund, Mubadala, Ocean Link, Orchid Asia, PAG, Snow Lake, Thomas H. Lee Partners, TPG and Warburg Pincus.Xiaoxi studied automation at Tsinghua University in Beijing, and actuarial science at the University of Hong Kong. He holds a Juris Doctor from Georgetown University Law Center. He has also passed all three levels of the chartered financial analyst (CFA) exam. From 2017 to 2021, Xiaoxi was the principal author of the China chapter in The Private Equity Review, an annual publication by Lexology In-Depth (formerly The Law Reviews).Xiaoxi is fluent in English, Mandarin, Cantonese and Shanghainese.<h4>Representative Experience</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li></ul><ul><li>The Carlyle Group, China International Trust Investment Corporation (CITIC) Limited and CITIC Capital Holdings in the US$2.08 billion acquisition of McDonald’s operations in mainland China and Hong Kong SAR and negotiation of a 20-year master franchise agreement, the largest McDonald’s franchise in the world.</li><li>An investor consortium, comprising Warburg Pincus Asia, General Atlantic Singapore Fund Pte., Ocean Link Partners, and Jinbo Yao, Chairman of the Board and Chief Executive Officer of 58.com, in the take-private of 58.com Inc., China’s largest online classifieds marketplace, at a valuation of approximately US$8.7 billion. This is the second-largest U.S. take-private in Asia to date.</li><li>The Special Committee of Qihoo 360 (NYSE: QIHU) in its US$9.3 billion going private transaction. This is the largest U.S. take-private in Asia to date.</li><li>The Special Committee of Nord Anglia (NYSE: NORD) in its US$4.3 billion going private transaction.</li><li>Plus, a provider of self-driving truck technology, in its proposed US$2.5 billion de-SPAC transaction and the related US$180 million PIPE financing from U.S. and Asian institutional investors.</li><li>BaiJiaYun in its reverse merger with NASDAQ-listed Fuwei Films (NASDAQ: FFHL).</li><li>Hillhouse, in various public and private investments in Asia and globally.</li><li>PAG in its US$200 million investment in Flash, a leading Southeast Asia logistics platform.</li><li>Sea Limited, a leading global consumer internet company, in the acquisition by its digital entertainment arm, Garena, of Phoenix Labs, an acclaimed independent games development company founded in Vancouver.</li><li>Consortium of Bain Capital and GIC in their acquisition of a minority interest in QuEST, a global engineering solutions provider.</li></ul>

林晓希律师在代表私募股权和投资基金客户处理其最复杂、最具战略性的交易方面拥有超过15年的丰富经验，其中包括控制权和杠杆收购、成长资本投资和上市公司并购。林律师是亚洲地区处理美国上市公司交易方面经验最丰富的律师之一，尤其擅长处理私有化交易、PIPE（私人投资公开股权）和SPAC/de-SPAC交易。林律师在代表金融投资者和企业处理并购交易方面拥有丰富的经验，尤其侧重于科技、消费、医疗保健和能源行业，以及与中国和美国相关的境内外投资。林律师曾代表美国和亚洲的多家金融投资者，包括Advantage Partners、贝恩资本、霸菱亚洲投资基金（现为殷拓亚洲私人资本）、博裕资本、凯雷、大钲资本、中国光大、中信资本/信宸资本、C资本、CPE源峰、加拿大养老金计划投资委员会（CPPIB）、德弘资本、Evenstar Capital、元生资本、广发资本、GP Investments、黑马资本、高瓴投资、KKR、马来西亚主权财富基金、穆巴达拉、鸥翎投资、兰馨亚洲、太盟投资集团、雪湖资本、THL基金、TPG和华平投资。林律师曾就读于北京清华大学自动化专业，毕业于香港大学精算专业，并拥有美国乔治城大学法学院的法律博士学位。他还通过了特许金融分析师（CFA）所有三个级别的考试。从2017年至2021年，林律师是《私募股权评论》中国章节的主要作者，该书是由Lexology In-Depth（原The Law Reviews）出版的年度刊物。林律师的英语、普通话、粤语和上海话均十分流利。<h4>具有代表性的交易</h4><ul><li>代表中国另类投资公司CPE源峰就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li></ul><ul><li>代表凯雷集团、中国国际信托投资公司和中信资本控股有限公司处理以20.8亿美元收购麦当劳在中国大陆和香港特别行政区的运营事宜，并就有关麦当劳全球最大特许经营权的20年期限《主特许经营协议》进行谈判。</li><li>代表由华平亚洲、General Atlantic Singapore Fund Pte.、鸥翎投资和58同城董事长兼首席执行官姚劲波组成的投资者财团处理以约87亿美元的估值对58同城进行私有化事宜。58同城是中国最大的在线分类信息网站。此次交易是迄今为止亚洲第二大美国私有化交易。</li><li>代表奇虎360（纽约证券交易所股票代码：QIHU）的特别委员会处理其93亿美元的私有化交易。此次交易是迄今为止亚洲最大的美国私有化交易。</li><li>代表诺德安达（纽约证券交易所股票代码：NORD）的特别委员会处理其43亿美元的私有化交易。</li><li>代表Plus处理其拟议进行的25亿美元de-SPAC交易，以及从美国和亚洲机构投资者获得1.8亿美元PIPE融资的事宜。Plus是一家自动驾驶卡车技术提供商。</li><li>代表百家云处理其与在纳斯达克证券交易所上市的富维薄膜公司（纳斯达克证券交易所股票代码：FFHL）进行的反向合并事宜。</li><li>代表高瓴投资处理其在亚洲和全球进行的各种公开和私人投资事宜。</li><li>代表太盟投资集团向Flash进行2亿美元投资的事宜。Flash是一家领先的东南亚物流平台。</li><li>代表冬海集团处理其数字娱乐公司Garena收购Phoenix Labs的事宜。冬海集团是一家领先的全球消费互联网公司。Phoenix Labs是一家总部位于温哥华的知名独立游戏开发公司。</li><li>代表贝恩资本和新加坡政府投资公司组成的财团处理收购全球工程解决方案提供商QuEST少数股权的事宜。</li></ul>

Xiaoxi Lin

Takaki Sato is a partner of Morrison Foerster Law Offices. He specializes in complex M&A transactions with a distinctive focus on data privacy. His experience includes advising clients on private equity acquisitions, growth investments, joint ventures, and public company transactions. Takaki also brings deep expertise in data privacy, and he counsels global tech companies on compliance, data-sharing frameworks, incident response, and evolving regulatory requirements. His transactional privacy work enables clients to accurately assess risks, particularly in data-driven businesses and high-stakes investments. Takaki received his LL.B. and his J.D. from the University of Tokyo, and his LL.M. from Columbia Law School. He completed his training at the Legal Training and Research Institute of the Supreme Court of Japan (63rd trainee). Takaki is a bengoshi admitted to practice in Japan and a member of the Dai-Ichi Tokyo Bar Association. He is also a qualified lawyer in New York.

Takaki Sato

Naoya Shiota is a partner of Morrison Foerster Law Offices and a member of the firm’s Private Equity Group. He has more than 20 years of experience advising private equity and corporate clients on cross-border M&A, finance, and other related transactions.He represents clients in a variety of industries including automotives, entertainment, and pharmaceuticals.Naoya received his LL.B. from the University of Tokyo and his LL.M. from Cornell Law School. He is a member of Daini Tokyo Bar Association.He is fluent in English and is a native speaker of Japanese.

Naoya Shiota

Gary has 30 years of experience advising clients on cross-border M&A and financing transactions. He has particular experience in the life sciences, tech, and media industries, where he has led on numerous inbound and outbound buyouts, joint ventures, and minority investments. Gary has advised on acquisitions in India, China, Brazil, Indonesia, Malaysia, Vietnam, and other parts of Southeast Asia, as well as in Europe and the United States. He counsels a variety of clients, including Daiwa Securities Group, FUJIFILM, the Hitachi Group, Mizuho Securities, SMBC Nikko Securities, and Taisho Pharmaceutical.Gary was born in Japan and is fluent in Japanese. During his law studies at Columbia University, he was a Harlan Fiske Stone scholar and a recipient of the Recognition of Achievement in International Law, with Honors. Gary also attended the University of Tokyo Graduate School as a Japan Ministry of Education Scholar. He received his B.A. and B.B.A. summa cum laude from University of Washington, where he was elected to Phi Beta Kappa.Gary is ranked as a Band 1 leading lawyer by Chambers Global and Chambers Asia-Pacific for his M&A and corporate law expertise. He has also been selected as a Stand-out Lawyer by Thomson Reuters in 2023, every year for the A-List Japan’s Top 100 Lawyers by Asia Business Law Journal since 2021 and by Lexology Index (formerly Who’s Who Legal) as a Thought Leader for M&A in Japan since 2023. He has been consistently selected as a leading lawyer in M&A and corporate law in Japan by The Legal 500 Asia Pacific (Hall of Fame), IFLR1000, and Best Lawyers.

Gary Mitchel Smith

Chuan Sun is Managing Partner of the Shanghai and Hong Kong offices.Chuan focuses his practice on cross-border M&A transactions; sophisticated technology, media, and telecom (TMT) transactions; and complex IP/commercial matters across Greater China.With more than 20 years of experience in both Asia and the U.S., Chuan regularly advises multinational corporations, state-owned enterprises, private companies, and PE/VC firms in complex cross-border M&A transactions, joint ventures, strategic alliances, and business separation transactions.Chuan has extensive experience in complex corporate-commercial and technology transactions across the Fintech, e-commerce, and broader TMT sectors. His work covers payment technology, eKYC, credit technology, blockchain, e-platform arrangements, R&D, co-development, technology collaborations, and IP licensing. He also advises on strategic outsourcing, manufacturing, distribution, supply, and franchising arrangements across various industries.Chuan regularly counsels clients on cutting-edge technology and IP regulatory matters, including Fintech, data privacy, cybersecurity, data localization, cross-border data transfers, cloud computing, telecommunications, telematics, and third-party payment services.Prior to joining MoFo, he worked in the Hong Kong office of a Magic Circle firm and the Chicago office of another leading international firm.Chuan co-authored the Hong Kong & mainland China chapters of Getting the Deal Through – Telecoms and Media, 2014, 2015 & 2016; the Hong Kong & mainland China chapters of Getting the Deal Through: Market Intelligence – Telecoms and Media, 2015; and the Hong Kong chapter of Sourcing World 2nd Edition 2015.Chuan is fluent in Mandarin and English.“Chuan Sun has a wealth of knowledge on his clients’ existing products and services offerings and a good understanding of what terms they are or are not willing to accept. This helps tremendously with contract negotiations.”“Chuan Sun has extensive experience in the technology space. Many other competitor firms in the technology space are not really pure IT lawyers, as they are more focus on privacy and trade marks or other related fields, as opposed to technology contracts such as SAP or Microsoft software license agreements. A normal general commercial lawyer would not be able to identify the same issues or raise the right questions, as they are not equipped with the technology know-how of the products and services, their benefits, and general industry standard terms and trending patterns in the market.” Legal 500 Asia Pacific 2020<h4>Representative Experience:</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li><li>OcuMension Therapeutics (HKSE: 01477), a Hong Kong Stock Exchange listed ophthalmic pharmaceutical platform in China in its acquisition of substantial assets valued at HK$1.28 billion (approximately US$165 million) from Alcon Inc., a global leader in eye care. The transaction involves asset purchase, global license, transition services and manufacture and supply arrangement and constitutes a very substantial transaction of OcuMension.</li><li>Ascendent Capital Partners in its US$1.66 billion privatization of Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), a leading international automation control system solutions provider. This is a rare transaction where a PE fund successfully acquires a US-listed Chinese company without forming a consortium with controlling shareholder or management. It is also the first and only U.S. take-private of a BVI-incorporated company involving a dissenter process. </li></ul><ul><li>Leading Global, China-Headquartered Fintech Company. Advise the company in connection with its first provision of blockchain and Real World Asset solutions in the fintech industry to a leading Chinese securities company for the latter’s first launch of structured product tokens, enabling secure, transparent, tamper-proof transactions for fixed-income and principal-protected tokenized products linked to US equity ETFs.</li><li>Leading Global, China-Headquartered Fintech Company. Advise the company in connection with the international expansion of its various business operations that are based on cutting-edge technologies, including blockchain and crypto, into multiple jurisdictions. </li></ul>

孙川是美富上海办公室和香港办公室的管理合伙人。孙川律师的执业领域集中在大中华区的跨境并购交易，复杂的技术、媒体和电信(TMT)交易以及复杂的知识产权/商务事宜。孙律师在亚洲和美国有20多年工作经验，他经常代理跨国公司、国有企业、私人企业和私募股权/风险投资机构处理复杂的跨境并购交易、合资、战略联盟和业务拆分等交易。孙律师在战略性的公司商务和技术交易方面也拥有极为丰富的经验，包括外包、制造、分销、供应与特许经营安排，以及跨行业知识产权许可安排等。他在TMT和知识产权监管方面的经验包括电信、电子商务、互联网、网络安全、数据隐私、云计算以及车联网。在加入美富前，孙律师在一家 “魔法圈”律所(Magic Circle)的香港办事处和另一家领先的国际律所的芝加哥办事处工作。孙律师与他人合著了2014，2015和2016版《让交易推进下去––电信与媒体》(Getting the Deal Through – Telecoms and Media)中的香港和中国大陆章节，2015年版《让交易推进下去：市场情报––电信与媒体》(Getting the Deal Through: Market Intelligence – Telecoms and Media)中的香港和中国大陆章节，以及2015年《采购世界》第二版(Sourcing World 2nd Edition)的香港章节。2018年《亚太法律500强》指出“孙川律师十分高效、负责和实际。他非常擅长处理IT协议，包括软件许可和IT采购合同的相关事宜。他也十分善于处理跨境TMT交易。”孙律师精通普通话和英语。<h4>具有代表性的交易 </h4><ul><li>代表中国另类投资公司CPE源峰 就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li><li>代表香港上市的中国眼科制药平台欧康维视生物医药(HKSE: 01477)处理其收购全球眼科护理领域的领导者爱尔康公司价值 12.8 亿港元（约 1.65 亿美元）重大资产的事宜。交易涉及资产收购，以及全球许可、过渡期服务、生产和供应安排等，是欧康维视的一项非常重大交易。</li><li>代表上达资本处理其以16.6亿美元对和利时自动化技术有限公司（纳斯达克证券交易所股票代码：HOLI）进行私有化事宜。和利时是一家领先的国际自动化控制系统解决方案提供商。这是一宗罕见的交易。在这宗交易中，私募股权基金在未与控股股东或管理层组建财团的情况下，就成功收购了在美国上市的中国公司。这也是首宗且唯一一宗涉及异议股东程序的，在英属维尔京群岛注册成立的公司的美国上市公司私有化交易。</li><li>代表一家总部位于中国的全球领先金融科技公司首次为金融科技行业提供区块链及现实世界资产（RWA）解决方案，协助一家中国头部证券公司首次发行结构化产品代币。该方案为挂钩美国股票ETF的固定收益及保本型代币化产品提供了安全、透明且防篡改的交易支持‌。</li><li>代表一家总部位于中国的全球领先金融科技公司处理基于区块链和加密货币等尖端技术开展的各项业务在多个司法管辖区进行国际扩张的事宜。</li></ul>

Chuan Sun

Managing Partner, Shanghai and Hong Kong

Mitsutoshi Uchida is a partner in the Corporate Department of Morrison Foerster Law Offices. He represents Japanese and non-Japanese clients in corporate transactions, including:<ul><li dir="ltr">Debt and equity capital markets transactions</li><li dir="ltr">Mergers and acquisitions</li><li dir="ltr">Financing transactions</li></ul>He also advises financial institutions and investment companies on Japanese regulatory matters.Mitsutoshi is a bengoshi, admitted to practice in Japan, and a qualified lawyer in New York.

Mitsutoshi Uchida

Tyler’s practice encompasses various aspects of transactional, regulatory, and contentious IP matters including technology transfer and licensing, IP and data-driven strategic cooperation, technical services and outsourcing arrangements, technology/IP-related advice in cross-border M&A and PE transactions, cybersecurity and data privacy, telecommunications regulation, pharmaceutical regulation, and patent protection. He advises a diverse range of multinational companies mainly in the life sciences, IT, telecommunications, manufacturing, and financial industries. In the words of his clients, “Tyler Xiu is an excellent up-and-coming lawyer, who is very proactive and helpful.” (The Legal 500 Asia Pacific).Tyler is fluent in Chinese and English.<h4>Representative Experience</h4><ul><li>CPE, a Chinese alternative investment firm, in connection with its US$350 million joint venture with Restaurant Brands International (RBI), one of the world's largest multinational fast food holding company, to operate Burger King in China which has around 1,250 restaurants in total. This transaction is one of the most significant private equity-led transactions in China’s consumer sector in 2025.</li></ul><ul><li>Advising Ensem Therapeutics, Inc., a biotechnology company focusing on high value and difficult-to-drug oncology targets, on its partnership with BeiGene, Ltd., a global biotechnology company, for BeiGene to acquire an exclusive global license to an Investigational New Drug (IND) application-ready oral cyclin-dependent kinase 2 (CDK2) inhibitor. Under the terms of the agreement, ENSEM will receive an upfront payment, and will be eligible for additional payments upon the achievement of certain development, regulatory, and commercial milestones, totaling up to $1.33 billion, in addition to tiered royalties.</li><li>Advising Jamieson Laboratories Ltd. and its parent company Jamieson Wellness Inc. (TSX:JWEL) in their partnership with DCP Capital, a leading international private equity firm founded by experienced private equity investors in Greater China. Through this transaction, DCP contributed US$35 million in exchange for a 33% interest in the Company’s Chinese operations and made a US$75 million preferred share investment in the Company.</li><li>Counseling a U.S. medical device company that focuses on the research, development, production, and marketing of respiratory care devices and services, in its engagement by a PRC medical device company for commissioned development of automatic high flow ventilators, including the associated technology licensing arrangements.</li><li>Advising a U.S. biopharmaceutical company on its strategic collaboration with a Chinese pharmaceutical company to develop and commercialize a bi-functional fusion protein inhibiting immune checkpoint and activating natural killer (NK) cells for the treatment of solid tumors, in the Asia Pacific Ex-Japan region.</li><li>Advising a leading pan-Asian retailer in Hong Kong on:<ul><li>A technology license agreement and joint venture with a digital retail platform for the purposes of providing online retailers with operational processes, marketing, supply, payment, merchandise, e-commerce, and customer services; and</li><li>Its licensing of technology and trademarks and provision of technical services in relation to the establishment of a joint venture for the purposes of developing a market-leading independent multi-partner coalition loyalty program for the ASEAN markets, and also the data privacy and data security issues under PRC law and cross-border data transfer issues that involve multiple jurisdictions in Asia. </li></ul></li><li>Advising an online game platform and game creation system on its trailblazing joint venture with another company to establish and launch the game platform in China, which would be the first foreign online game platform with user-generated games and revenue-sharing to obtain a government license in the PRC. </li><li>Advising a leading Chinese investment fund on its strategic partnership with a leading U.S. IT software company to establish the financial cloud infrastructure for the People’s Bank of China, key state banks, and the governments of various major cities.</li><li>Assisting a leading global digital library with the amendment of its license agreement with a Chinese Internet technology company, under which the tech company is granted a license to allow users to access the client’s digital library of sheet music.</li><li>Advising a PRC advanced semiconductor materials company on obtaining a technology license and associated support services from a German specialty chemicals and equipment company, with respect to chemicals for wafer level packaging and wafer level semiconductor interconnect.</li></ul>

修徇泽律师擅长处理知识产权项目所涉及的交易、监管、争议解决等多个层面的法律问题，包括技术转让和许可、知识产权及数据驱动的战略合作、技术服务和外包、跨境并购/私募股权交易所涉及的技术及知识产权问题、网络安全及数据隐私保护、电信监管，药品监管、以及专利保护等。修律师主要为生命科学、信息技术、电信、制造和金融行业的跨国客户提供法律意见。客户曾如此评价他：“修律师是一位崭露头角的出色律师，他非常积极主动，提供富有成效的建议。”（《亚太法律500强》）修律师精通中英文。<h4>具有代表性的项目 </h4><ul><li>代表中国另类投资公司CPE源峰就其与世界上最大的餐饮公司之一餐饮品牌国际集团（Restaurant Brands International，简称 RBI）成立价值3.5亿美元的合资企业。该合资企业将负责汉堡王在中国的运营，目前在全国拥有约 1,250 家餐厅。本次交易是 2025 年中国消费行业中由私募股权基金主导的最具代表性交易之一。</li></ul><ul><li>代表聚焦肿瘤治疗领域高价值、难成药靶点的生物科技公司昂胜医药(Ensem Therapeutics, Inc.)达成一项与全球生物科技公司百济神州(BeiGene, Ltd.)的授权合作协议。百济神州将获得一款在研、即将提交新药临床试验(IND)申请的口服细胞周期蛋白依赖性激酶2(CDK2)抑制剂的全球独家许可权利。根据协议条款，昂胜将获得一笔首付款，并基于取得的特定研发、注册和商业化里程碑，有权获得至多13.3亿美元的总交易额款项，以及分级销售特许使用费。</li><li>代表Jamieson Laboratories Ltd.及其母公司健美生公司（多伦多证券交易所：JWEL）处理其与DCP Capital达成合作的事宜。DCP Capital是一家由大中华区经验丰富的私募股权投资者所创立的领先的国际私募股权公司。通过本次交易，德弘出资3500万美元，获得该公司中国业务33%的权益，并以优先股形式对该公司进行7500万美元的投资。</li><li>代表一家专注于研究、开发、生产和销售呼吸护理设备和服务的美国医疗设备公司处理其受一家中国医疗设备公司委托开发自动高流速呼吸机的事宜，包括相关的技术许可安排。</li><li>代表美国某生物制药公司与一家中国制药公司进行战略合作，在除日本外的亚太地区开发和商业化一种抑制免疫检查点和激活自然杀伤细胞治疗实体瘤的双功能融合蛋白的事宜。</li><li>代表一家位于香港的领先的泛亚洲零售商： </li><ul><li>处理其与一家数字零售平台签订技术许可协议并成立合资企业，为在线零售商提供运营流程、营销、供应、支付、商品、电子商务和客户服务；以及</li><li>成立一家合资企业，并向该合资企业授权技术和商标并提供技术服务，以便在东盟市场开发市场领先的独立多合作伙伴联盟忠诚度计划。同时处理涉及中国法律规定的数据隐私和数据安全问题，以及涉及亚洲多个司法管辖区的跨境数据传输问题。</li></ul><li>代表一家网络游戏平台和游戏创作系统公司处理其与另一家公司成立合资企业，在中国建立并推出游戏平台，该游戏平台将成为首个在中国获得政府许可的用户生成游戏和收入共享的外国网络游戏平台。</li><li>代表一家领先的中国投资基金处理其与一家领先的美国IT软件公司建立战略合作伙伴关系，为中国人民银行、主要国有银行和各大城市政府建立金融云基础设施。</li><li>代表某全球领先的乐谱数字图书馆处理其与某中国互联网科技公司修改许可协议的事宜。依据该许可协议，该科技公司被授予许可允许其用户访问乐谱数字图书馆。</li><li>代表一家中国先进的半导体材料公司处理其从一家德国特殊化学品和设备公司获得技术许可和相关支持服务的事宜，其中涉及晶圆级封装和晶圆级半导体互连的化学品。</li></ul>